Aline Maillard

A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

Karim Fizazi, Aline Maillard, Nicolas Penel et al. · Annals of Oncology · 2019 · 240 citations · Full text

Malignant Disease, Medicine, Phase Iii Trial +8

Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial

Cédric Schweitzer, Antoine P. Brézin, Béatrice Cochener et al. · The Lancet · 2020 · 119 citations · Full text

Ophthalmic Surgery, Ophthalmology, Cost-effectiveness Trial +5

The Age‐Well randomized controlled trial of the Medit‐Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adults

Géraldine Poisnel, Eider M. Arenaza‐Urquijo, Fabienne Collette et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 97 citations · Full text

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Yungan Tao, Anne Aupérin, Xu-Shan Sun et al. · European Journal of Cancer · 2020 · 91 citations · Full text

LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

Jean Bourhis, Yungan Tao, Xiaonan Sun et al. · Annals of Oncology · 2021 · 78 citations

Neuro-oncology, Radiation Medicine, Radiation Therapy +8